Shenzhen RuiJin Pharmaceutical Co.,Ltd 86-188-06592208
Polypeptide Crystalline Powder Human Growth Hormone Somatropin CJC-1295 Without DAC

Polypeptide Crystalline Powder Human Growth Hormone Somatropin CJC-1295 Without DAC

  • High Light

    polypeptide supplements


    hormone powder

  • CAS
  • MF
  • Appearance
    White Crystalline Powder
  • MOQ
  • MW
  • Mass Balance
  • Place of Origin
  • Brand Name
    CJC-1295 Without DAC
  • Certification
  • Model Number
  • Minimum Order Quantity
  • Price
  • Packaging Details
    In disguised,as your requirements.
  • Delivery Time
    within 24hours after you pay the order
  • Payment Terms
    T/T, Western Union, MoneyGram,Bitcoin
  • Supply Ability
    5000Grams per month

Polypeptide Crystalline Powder Human Growth Hormone Somatropin CJC-1295 Without DAC

Polypeptide Crystalline Powder Human Growth Hormone Somatropin CJC-1295 Without DAC


Quick Detail:


Product Name CJC-1295 Without DAC
Synonyms CJC-1295 Acetate;CJC-1295; CJC-1295 No DAC, CJC-1295 W/O DAC
CAS No. 863288-34-0
MF C152H252N44O42
MW 3367.97
Sequence Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-Lys(Maleimidopropionyl)-NH2
Categories Peptides
Appearance White Lyophilized Powder
Purity 99.19% by HPLC
Specification 2mg/vial
Solubility Soluble in water(sterile water)
Identity (ESI-MS) 3367.97±3.0
Storage Lyophilized CJC-1295 Without DAC is stable at room temperature for 90 days, however it should be stored in a freezer below -8℃ for any extended period of time. After reconstituting CJC-1295 Without DAC should be refrigerated at temperatures not to exceed 36 F.
Usage An obstetric drug used to control postpartum hemorrhaging.
Sample PIC Polypeptide Crystalline Powder Human Growth Hormone Somatropin CJC-1295 Without DAC 0



Description and Applications:


Modified Growth Releasing Factor aminos 1-29, usually referred to as Modified GRF (1-29) or

“ModGRF(1-29),” also known as CJC-1295 without DAC, is a synthetic analog of the endogenous

peptide signaling hormone Growth Hormone Releasing Hormone (GHRH). Endogenously produced

GHRH has 44 amino acids in its chain structure. A truncated synthetic form of GHRH called Sermorelin

or GRF 1-29 has 29 amino acids; Modified GRF (1-29) is further changed in that it has four substituted

aminos in its chain that serve the purposes of preventing degradation and oxidation in manufacture

and transport as well as in vivo, while also increasing binding affinity to the GHRH receptors.

Modified GRF (1-29) is not CJC-1293 nor should it be referred to as such. Modified GRF (1-29)

is identical to the portion of CJC-1295 DAC that is not bound to MPA, minus the lysine. The

presence of lysine in a literal “CJC without DAC” in the absence of MPA would have the opposite

effect of DAC: it would drastically reduce the active life of the peptide to that of Sermorelin. Modified

GRF (1-29) is the same as CJC-1295 with out DAC.


CJC-1295 DAC and CJC-1295 (also known as Modified GRF 1-29) are both Releasing Hormones (GHRH). Their action in the human body is identical but the difference between the two peptides are the span of the half-life. Modified GRF 1-29 and Sermorelin have a very short acting half-life of about 30 minutes, while CJC-1295 DAC has a half-life that can last up to approximately 8 days. Many a scientist have reported that the short half-life of Sermorelin and Modified GRF 1-29 is considered to be much more natural as they produce a short pulse of Human Growth Hormone.




A subcutaneous injection is preferred. Wash hands and gather materials. Cleanse the top of the vial with an alcohol wipe. Use an insulin syringe to draw the desired dose from the vial. Gently tap /flick the syringe and remove air bubbles. Cleanse the skin site with an alcohol based rub to prevent infection. Pinch the skin to create a fold of subcutaneous fat. Gently insert the needle into the fat, and inject the contents of the syringe. Wipe the injection site with alcohol and dispose of the used syringe in a puncture proof container.




CJC-1295 Peptide is generally very well tolerated by most individuals dosing with 100mcg per injection. The most common side effect noted is a head "rush" and throbbing of the temples which may start 10 minutes post injection and lasts up to 20 minutes. This side effect is not serious, and is caused by a release of GABA (gamma-aminobutyric acid, one neurotransmitter) in the brain. Some users take this as a good sign their peptide is working to stimulate HGH release.




Without a doubt, CJC-1295 is better than HGH. CJC-1295 causes an increase in your HGH production and helps to stimulate IGF-1 as well. It is also less expensive than HGH, and produces the same loss of body fat and muscular growth with fewer injections.